Search results for: 'drug ad data'

Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...

Edge computing refers to processing and computing data as close to the point of origin as feasible, enabling near-real-time decisions and insights to drive better outcomes. It is computing that moves intelligence, processing, analytics, and communication capabilities closer to the data source. The goal is to reduce latency while ensuring highly ef...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

This Frost & Sullivan study comprehensively analyzes the Latin American data center colocation services market, covering strategic imperatives/challenges, insights, growth drivers and restraints, trends, market sizing and forecasts, competitive landscape, market share, 17 company profiles of the largest participants, and growth opportunities. The g...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

Server-side ad insertion has normally been about tackling the problems of ad blocking and device fragmentation. But the industry is now seeing platform shifts that change the sweet spot of ad stitching towards live and catch-up TV. Client-side ad SDKs have grown in sophistication, the platforms they run have become more capable and the transition t...

The conventional drug discovery and diagnostics technologies are unable to cope up with the current disease management practices. To this end, researchers have explored possibilities beyond life sciences. Specifically, they have figured out that the use of engineering principles to biological systems can revolutionize the drug discovery and diagnos...

With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...